COVID-19 Bibliography First Edition 31 March 2020 by Dr Yahia Bakelli Taibah University
Total Page:16
File Type:pdf, Size:1020Kb
COVID-19 Bibliography First edition 31 March 2020 By Dr Yahia Bakelli Taibah University This bibliography is a monthly compilation of references from multiple portals, websites and information sources throughout the web. It aims to give immunology researchers, biologists, laboratories, doctors and decision makers a maximum of links to useful academic peer reviewed papers in one link. This compilation is a monthly updated list which mainly contains bibliographic references to papers published in Anglo-Saxon journals but also those published in French and Arabic. We plan to extend the bibliography to dissertations, proceedings and reports. Also we plan to extend this compilation to Japanese and Spanish publications. The first edition of the compilation is about 838 references structured as following: Bibliographies, databases and portals (5) Books (8) Scientific and peer reviewed papers (714) Datasets and Repositories (111) For further information please contact at: Dr Yahia Bakelli Email: [email protected] 1 Bibliographies, databases and portals 1. The Frontiers Coronavirus Knowledge Hub https://coronavirus.frontiersin.org/ 2. Wikipedia Portal: Coronavirus disease 2019. Wikipedia, the free encyclopedia https://en.wikipedia.org/wiki/Portal:Coronavirus_disease_2019 3. Coronavirus disease (COVID-19) Pandemic The World Health Organisation WHO https://www.who.int/emergencies/diseases/novel-coronavirus-2019 4. Coronavirus disease (COVID-19) The United Nations organization https://www.un.org/en/coronavirus 5. How WhatsApp can help you stay connected during the coronavirus (COVID-19) pandemic Whattsapp https://www.whatsapp.com/coronavirus/ 2 Books and Book chapters 1. Coronavirus. Vohr, Hans-Werner. In: Encyclopedic Reference of Immunotoxicology. 2005, p163-163. 1/9p. ISBN: 9783540441724 2. Coronavirus. Enjuanes, Luis, Cavanagh, Dave. in: Springer Index of Viruses. 2002, p272-280. 9p. ISBN : 9783540671671 3. Middle East respiratory syndrome. In: Columbia Electronic Encyclopedia, 6th Edition. 2020, p1-1. 1p. ISBN : 9780787650155 4. 101 Coronavirus Jokes: Laughing Your Way Through Troubled Times. by Dr. Hackinkoff 5. MERS Coronavirus: Methods and Protocols (Methods in Molecular Biology) a. by Rahul Vijay | Dec 28, 2019 6. Coronavirus Replication and Reverse Genetics (Current Topics in Microbiology and Immunology) a. by Luis Enjuanes | Nov 23, 2004 7. Fast Recovery Secrets From Coronavirus, Stroke, Alzheimer And Cancer That Big Pharma Don't Want You To Know a. by Igor Kryan | Mar 3, 2020 8. The Wuhan Coronavirus Safety Handbook: Survival Manual to the 2019-nCoV & COVID Pandemic Outbreak, Lockdowns & Quarantines a. by Dr Daniel C Paul M D | Mar 3, 2020 3 Scientific and peer reviewed papers1 1. "COVID-19 treatment and vaccine tracker" (PDF). Milken Institute. 26 March 2020. Retrieved 26 March 2020. Lay summary. 2. Carey K (February 26, 2020). "Increasing number of biopharma drugs target COVID-19 as virus spreads". BioWorld. Retrieved 1 March 2020. 3. Garde D (19 March 2020). "An updated guide to the coronavirus drugs and vaccines in development". STAT. Retrieved 21 March 2020. 4. "Draft landscape of COVID-19 candidate vaccine" (PDF). World Health Organization. 13 March 2020. Retrieved 21 March 2020. 5. Knapp A (13 March 2020). "Coronavirus Drug Update: The Latest Info On Pharmaceutical Treatments And Vaccines". Forbes. Retrieved 21 March 2020. 6. Kupferschmidt, Kai; Cohen, Jon (22 March 2020). "WHO launches global megatrial of the four most promising coronavirus treatments". Science Magazine. doi:10.1126/science.abb8497. Retrieved 27 March 2020. 7. "First regulatory workshop on COVID-19 facilitates global collaboration on vaccine development". European Medicines Agency. 18 March 2020. Retrieved 21 March 2020. 8. "Coronavirus (COVID-19) Update: FDA Continues to Facilitate Development of Treatments". US Food and Drug Administration. 19 March 2020. Retrieved 21 March 2020. 9. "China approves first anti-viral drug against coronavirus Covid-19". Clinical Trials Arena. 18 February 2020. Retrieved 21 March 2020. 10. "Chinese Vaccine Approved for Human Testing at Virus Epicenter". Bloomberg News. 19 March 2020. Retrieved 21 March 2020. 11. Dhama K, Sharun K, Tiwari R, Dadar M, Malik YS, Singh KP, et al. (March 2020). "COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics". Human Vaccines and Immunotherapeutics: 1–7. doi:10.1080/21645515.2020.1735227. ISSN 2164-5515. PMID 32186952. 12. Zhang L, Liu Y (March 2020). "Potential interventions for novel coronavirus in China: A systematic review". Journal of Medical Virology. 92 (5): 479–90. doi:10.1002/jmv.25707. ISSN 0146-6615. PMID 32052466. 13. Fox, Maggie (19 March 2020). "Drug makers are racing to develop immune therapies for Covid-19. Will they be ready in time?". Stat. Retrieved 21 March 2020. 14. Chan M (19 March 2020). "Chinese military scientists ordered to win global race to develop coronavirus vaccine". South China Morning Post. Retrieved 22 March 2020. 15. "CEPI welcomes UK Government's funding and highlights need for $2 billion to develop a vaccine against COVID-19". Coalition for Epidemic Preparedness Innovations, Oslo, Norway. 6 March 2020. Retrieved 23 March 2020. 16. Kelland K (10 March 2020). "Epidemic response group ups coronavirus vaccine funding to $23.7 million". Reuters. Retrieved 21 March 2020. 17. "Government of Canada funds 49 additional COVID-19 research projects – Details of the funded projects". Government of Canada. 23 March 2020. Retrieved 23 March 2020. 1 In this first edition references were arranged by date of publication. But for the next editions it will be organized in alphabetical order of authors. 4 18. Abedi M (23 March 2020). "Canada to spend $192M on developing COVID-19 vaccine". Global News. Retrieved 24 March 2020. 19. Li G, De Clercq E (March 2020). "Therapeutic options for the 2019 novel coronavirus (2019-nCoV)". Nature Reviews: Drug Discovery. 19 (3): 149–150. doi:10.1038/d41573-020- 00016-0. PMID 32127666. 20. Li, G.; De Clercq, E. (2020). "Therapeutic options for the 2019 novel coronavirus (2019- nCoV) - Supplementary Table 1: Summary of antiviral compounds against human coronaviruses". Nature Reviews: Drug Discovery. 19 (3): 149–150. doi:10.1038/d41573- 020-00016-0. PMID 32127666. 21. Dong, Liying; Hu, Shasha; Gao, Jianjun (2020-02-29). "Discovering drugs to treat coronavirus disease 2019 (COVID-19)". Drug Discoveries and Therapeutics. 14 (1): 58–60. doi:10.5582/ddt.2020.01012. ISSN 1881-7831. PMID 32147628. 22. Harrison, Charlotte (2020-02-27). "Coronavirus puts drug repurposing on the fast track". Nature Biotechnology. doi:10.1038/d41587-020-00003-1. ISSN 1087-0156. PMID 32205870. 23. Cheng, Matthew P.; Lee, Todd C. Lee; Tan, Darrell H.S.; Murthy, Srinivas (26 March 2020). "Generating randomized trial evidence to optimize treatment in the COVID-19 pandemic" (PDF). Canadian Medical Association Journal: cmaj.200438. doi:10.1503/cmaj.200438. ISSN 0820-3946. Retrieved 27 March 2020. 24. "The Drug Development Process". US Food and Drug Administration. 4 January 2018. Retrieved 21 March 2020. 25. Grenfell R, Drew T (17 February 2020). "Here's Why It's Taking So Long to Develop a Vaccine for the New Coronavirus". ScienceAlert. Archived from the original on 28 February 2020. Retrieved 26 February 2020. 26. Preston E (19 March 2020). "Why will a coronavirus vaccine take so long?". The Boston Globe. Retrieved 21 March 2020. 27. "Call to pool research resources into large multi-centre, multi-arm clinical trials to generate sound evidence on COVID-19 treatments". European Medicines Agency. 19 March 2020. Retrieved 21 March 2020. 28. "Information for clinicians on therapeutic options for COVID-19 patients". US Centers for Disease Control and Prevention. 21 March 2020. Retrieved 22 March 2020. 29. Strovel J, Sittampalam S, Coussens NP, Hughes M, Inglese J, Kurtz A, Andalibi A, Patton L, Austin C, Baltezor M, Beckloff M, Weingarten M, Weir S (July 1, 2016). "Early Drug Discovery and Development Guidelines: For Academic Researchers, Collaborators, and Start-up Companies". Assay Guidance Manual. Eli Lilly & Company and the National Center for Advancing Translational Sciences. PMID 22553881. 30. Taylor, David (2015). "The Pharmaceutical Industry and the Future of Drug Development". Issues in Environmental Science and Technology. Royal Society of Chemistry: 1–33. doi:10.1039/9781782622345-00001. ISBN 978-1-78262-189-8. 31. "Vaccine Testing and the Approval Process". US Centers for Disease Control and Prevention. 1 May 2014. Retrieved 21 March 2020. 32. Kessler DA, Feiden KL (March 1995). "Faster Evaluation of Vital Drugs". Scientific American. 272 (3): 48–54. Bibcode:1995SciAm.272c..48K. doi:10.1038/scientificamerican0395-48. PMID 7871409. 5 33. "Vaccine Product Approval Process". US Food and Drug Administration. 30 January 2018. Retrieved 21 March 2020. 34. Kaiser J., Aziz (1 April 2018). "FDA update (2018) – The FDA's new drug approval process: Development and premarket applications". Drug Development and Delivery. Retrieved 25 March 2020. 35. Fogel DB (7 August 2018). "Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: A review". Contemporary Clinical Trials Communications. 11: 156–64. doi:10.1016/j.conctc.2018.08.001. ISSN 2451-8654. PMC 6092479. PMID 30112460. 36. "R&D costs are on the rise". Medical Marketing and Media. 38 (6): 14. June 1, 2003. Archived from the original